Results 271 to 280 of about 106,911 (284)

Selective Laser Trabeculoplasty After Medical Treatment for Glaucoma or Ocular Hypertension.

JAMA Ophthalmol
Konstantakopoulou E, Gazzard G, Garway-Heath D, Adeleke M, Ambler G, Vickerstaff V, Bunce C, Nathwani N, Barton K, LiGHT Trial Study Group.   +9 more
europepmc   +1 more source

Development of Postoperative Ocular Hypertension After Phacoemulsification for Removal of Cataracts in Dogs. [PDF]

Animals (Basel)
Kang MG, Kim CH, Lee SH, Cho JH.
europepmc   +1 more source

Isorhamnetin Alleviates Renal Fibrosis Induced by Renal Tubular Epithelial Cell Senescence Via Inhibition of the IL‐6/IL‐6R Signaling Pathway

iMetaMed, EarlyView.
IL‐6 from RTECs upregulates TGF‐β in macrophages, promoting fibroblast transdifferentiation. Isorhamnetin inhibits this effect. ABSTRACT Chronic kidney disease (CKD) is a major global health issue. Kidney fibrosis is a key mechanism leading to end‐stage renal disease.
Weifei Liang, Xiangqiu Chen, Tao Wu, Xichun Zheng, Shaohua Zeng, Qingchun Zhou, Wen Ma, Hao Lin, Donglin Sun   +8 more
wiley   +1 more source

Pharmacogenomics of steroid-induced ocular hypertension: relationship to high-tension glaucomas and new pathophysiologic insight

Song Z, Pany S, Guo S, Mazumder AG, Itakura T, Huang J, Magarychoff E, Gurinovich A, Benchek PH, Stamer WD, Price FW, Willoughby CE, Senthilkumari S, George RJ, Chitipothu S, Lass JH, Iyengar SK, Schwartz SG, Griswold AJ, Sebastiani P, Price MO, Fini ME.   +21 more
europepmc   +1 more source

Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine^®) with Latanoprost Eye Drops (Xalatan^®) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension. [PDF]

J Clin Med
Beck A, Rauschkolb-Olk KT, Welzel AM, Wolfrum P, Korb C, Schmidtmann I, Boehm EW, Lorenz K.   +7 more
europepmc   +1 more source

Assessing Effects of Riboflavin/UV‐A Cross‐Linking on Aqueous Outflow Facility, Corneal Biomechanics and Their Association With Intraocular Pressure

Journal of Biophotonics, EarlyView.
Our study demonstrates that UV cross‐linking (CXL) reduces outflow facility while increasing corneal elasticity across IOP levels of 20–40 mmHg, measured using direct manometry and non‐contact optical coherence elastography. These results highlight both parameters as potential indicators for evaluating CXL effectiveness and monitoring keratoconus ...
Yilong Zhang, Zhengshuyi Feng, Xingyu Jiang, Robert Scott, Ying Yang, Chunhui Li, Zhihong Huang   +6 more
wiley   +1 more source

Neuroprotective Effect of the Combination of Citicoline and CoQ10 in a Mouse Model of Ocular Hypertension. [PDF]

Antioxidants (Basel)
Matamoros JA, Rubio-Casado S, Fernández-Albarral JA, Martínez-López MA, Salobrar-García E, Marco EM, Paleo-García V, de Hoz R, López-Cuenca I, Elvira-Hurtado L, Sánchez-Puebla L, Ramírez JM, Salazar JJ, López-Gallardo M, Ramírez AI.   +14 more
europepmc   +1 more source

A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension. [PDF]

Adv Ther
Konstas AG, Garhöfer G, Lübke J, Voykov B, Ropo A.   +4 more
europepmc   +1 more source

Vitamin K1 Alleviates Retinal Inflammation Following Acute Ocular Hypertension by Modulating Microglial Ferroptosis. [PDF]

Invest Ophthalmol Vis Sci
Chen X, Rong Y, Jiang Y, Zhang Q, Xiang S, Chen Z, Chen W, Zhang H, Deng C, Wang J.   +9 more
europepmc   +1 more source

Latanoprostene Bunod 0.024% Early Experience Program (LEEP): A Canadian Initiative for Open-Angle Glaucoma and Ocular Hypertension. [PDF]

Ophthalmol Ther
Yan D, Hutnik CML, Harasymowycz P.
europepmc   +1 more source